Use of low molecular weight heparin in postangioplasty management.
The results of using low molecular weight heparin (LMWH) in postangioplasty management are examined. In comparison to intravenous unfractionated heparin, subcutaneous LMWH caused less groin complications and was simpler and cheaper to be administered by the medical personnel. The incidence of ischaemic complications after angioplasty including acute closure and myocardial infarction, however, remained similar and was not excessive. Subcutaneous administration of LMWH provides and alternative simple and cost-effective strategy for postangioplasty management.
Chow
W H
WH
Cardiac Medical Unit, Grantham Hospital, Hong Kong, Hong Kong.
Fan
K
K
Chow
T C
TC
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D003327:Coronary Disease / Q000628:therapy; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000191:economics*; D006801:Humans; D008297:Male; D008875:Middle Aged
D006495:Heparin, Low-Molecular-Weight